Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

NYSE:PRLB - New York Stock Exchange, Inc. - US7437131094 - Common Stock - Currency: USD

38.04  +0.02 (+0.05%)

After market: 38.04 0 (0%)

Fundamental Rating

5

Taking everything into account, PRLB scores 5 out of 10 in our fundamental rating. PRLB was compared to 128 industry peers in the Machinery industry. No worries on liquidiy or solvency for PRLB as it has an excellent financial health rating, but there are worries on the profitability. PRLB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
PRLB had a positive operating cash flow in the past year.
PRLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years PRLB had a positive operating cash flow.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.02%, PRLB is doing worse than 60.16% of the companies in the same industry.
PRLB's Return On Equity of 2.27% is on the low side compared to the rest of the industry. PRLB is outperformed by 64.06% of its industry peers.
With a Return On Invested Capital value of 2.21%, PRLB is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for PRLB is significantly below the industry average of 10.72%.
Industry RankSector Rank
ROA 2.02%
ROE 2.27%
ROIC 2.21%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 2.99%, PRLB perfoms like the industry average, outperforming 41.41% of the companies in the same industry.
PRLB's Profit Margin has declined in the last couple of years.
The Operating Margin of PRLB (4.64%) is worse than 64.06% of its industry peers.
PRLB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 44.36%, PRLB belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
In the last couple of years the Gross Margin of PRLB has declined.
Industry RankSector Rank
OM 4.64%
PM (TTM) 2.99%
GM 44.36%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
PRLB has less shares outstanding than it did 1 year ago.
PRLB has less shares outstanding than it did 5 years ago.
PRLB has a better debt/assets ratio than last year.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 8.17 indicates that PRLB is not in any danger for bankruptcy at the moment.
PRLB has a better Altman-Z score (8.17) than 91.41% of its industry peers.
The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
PRLB has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. PRLB outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PRLB is not too dependend on debt financing.
PRLB's Debt to Equity ratio of 0.00 is amongst the best of the industry. PRLB outperforms 85.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 8.17
ROIC/WACC0.22
WACC10.07%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

PRLB has a Current Ratio of 3.13. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PRLB (3.13) is better than 78.13% of its industry peers.
A Quick Ratio of 2.92 indicates that PRLB has no problem at all paying its short term obligations.
PRLB has a Quick ratio of 2.92. This is amongst the best in the industry. PRLB outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 2.92
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

PRLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.24%.
Measured over the past years, PRLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.19% on average per year.
The Revenue has decreased by -1.33% in the past year.
Measured over the past years, PRLB shows a small growth in Revenue. The Revenue has been growing by 1.78% on average per year.
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%

3.2 Future

Based on estimates for the next years, PRLB will show a decrease in Earnings Per Share. The EPS will decrease by -0.91% on average per year.
The Revenue is expected to grow by 3.54% on average over the next years.
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.47%
Revenue Next 2Y3.54%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.38 indicates a rather expensive valuation of PRLB.
Compared to the rest of the industry, the Price/Earnings ratio of PRLB is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.35. PRLB is around the same levels.
With a Price/Forward Earnings ratio of 23.77, PRLB is valued on the expensive side.
Based on the Price/Forward Earnings ratio, PRLB is valued a bit more expensive than 60.94% of the companies in the same industry.
PRLB is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.38
Fwd PE 23.77
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

PRLB's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, PRLB is valued cheaply inside the industry as 82.03% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.49
EV/EBITDA 13.55
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.91%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PRLB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (6/20/2025, 8:04:00 PM)

After market: 38.04 0 (0%)

38.04

+0.02 (+0.05%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners93.25%
Inst Owner Change-0.6%
Ins Owners1.05%
Ins Owner Change3.43%
Market Cap904.21M
Analysts76.36
Price Target45.9 (20.66%)
Short Float %3.49%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.65%
Min EPS beat(2)10.87%
Max EPS beat(2)16.42%
EPS beat(4)4
Avg EPS beat(4)19.58%
Min EPS beat(4)7.67%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)28.54%
EPS beat(12)11
Avg EPS beat(12)24.23%
EPS beat(16)13
Avg EPS beat(16)20.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-0.63%
Max Revenue beat(2)0.02%
Revenue beat(4)2
Avg Revenue beat(4)-0.4%
Min Revenue beat(4)-2.44%
Max Revenue beat(4)1.46%
Revenue beat(8)4
Avg Revenue beat(8)0.08%
Revenue beat(12)6
Avg Revenue beat(12)0.05%
Revenue beat(16)7
Avg Revenue beat(16)-0.07%
PT rev (1m)0%
PT rev (3m)1.5%
EPS NQ rev (1m)1.79%
EPS NQ rev (3m)1.91%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.33%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)1.53%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.66%
Valuation
Industry RankSector Rank
PE 24.38
Fwd PE 23.77
P/S 1.81
P/FCF 13.49
P/OCF 12.08
P/B 1.38
P/tB 2.5
EV/EBITDA 13.55
EPS(TTM)1.56
EY4.1%
EPS(NY)1.6
Fwd EY4.21%
FCF(TTM)2.82
FCFY7.41%
OCF(TTM)3.15
OCFY8.28%
SpS21
BVpS27.63
TBVpS15.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.02%
ROE 2.27%
ROCE 3.43%
ROIC 2.21%
ROICexc 2.58%
ROICexgc 5.26%
OM 4.64%
PM (TTM) 2.99%
GM 44.36%
FCFM 13.43%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 22.16%
Cap/Sales 1.57%
Interest Coverage 250
Cash Conversion 127.85%
Profit Quality 449.12%
Current Ratio 3.13
Quick Ratio 2.92
Altman-Z 8.17
F-Score6
WACC10.07%
ROIC/WACC0.22
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.24%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%-17.5%
EPS Next Y-14.33%
EPS Next 2Y-0.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%-1.32%
Revenue Next Year2.47%
Revenue Next 2Y3.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.12%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year53.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.28%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y11.91%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%